Using 80-kVp CT pulmonary angiography for patients suspected of CT pulmonary embolism reduces radiation exposure, significantly increases contrast medium attenuation in the pulmonary arteries, and doesn’t look much different from standard dose, according to a study presented Tuesday at the RSNA meeting.
Using 80-kVp CT pulmonary angiography for patients suspected of CT pulmonary embolism reduces radiation exposure, significantly increases contrast medium attenuation in the pulmonary arteries, and doesn’t look much different from standard dose, according to a study presented Tuesday at the RSNA meeting.
Radiologists are always looking for a way to reduce dose for their patients while also maintaining image quality. For patients suspected of pulmonary emboli, Dr. Guilia Zamboni, from the radiology department at the University of Verona in Italy, and colleagues, compared 50 patients undergoing CT pulmonary angiography (CTPA) at 80 kVp with 50 patients undergoing CTPA at 120 kVp.
“If we look at a head-to-head comparison between the two protocols, we don’t see significant differences between them just eyeballing the images,” Zamboni said.
The researchers also found mean attenuation was significantly higher in the test group than in the control group in the main pulmonary trunk, right pulmonary artery, and left pulmonary artery. However, no significant difference was observed in attenuation of the aorta.
In addition, the radiation dose was significantly lower in the test group than in the control group, as measured by CT dose index (5.483 ± 0.7778 mGy versus 13.1 ± 3.855 mGy; p <0.0001) and dose length product (173.87 ± 24.323 mGy x cm versus 418.52 ± 109.28 mGy x cm; p <0.0001).
Zamboni also said at first the researchers were wary of scanning patients weighing more than 120 kg with the reduced voltage because they were afraid they would get with nondiagnostic scans. But after scanning more and more patients with increasing confidence, they scanned a 200-kg patient at the lower voltage and the image quality was fine for him as well.
“The image quality was deemed diagnostic, though not the best I’ve ever done,” Zamboni said.
The biggest limitation is not weight, but whether a patient can raise his or her arms, she said.
“If the patient cannot raise their arms above their shoulders, we don’t use the lower voltage protocol because it would significantly lower the image quality,” Zamboni said.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.